Geroscience-Guided Repurposing of FDA-Approved Drugs to Target Aging: A 2025 Update

Abstract

Common chronic diseases represent the greatest driver of rising healthcare costs, as well as declining function, independence, and quality of life. Geroscience-guided approaches seek to delay the onset and progression of multiple chronic conditions by targeting fundamental biological pathways of aging.